CHI and Bio-IT World's "Structure-Based Design" Conference to be held on June 8-10, 2011 in Cambridge, MA, will feature a new session: New Targets and Drug Modalities.
The following presentations have just been added and are scheduled on Friday, June 10 from 1:30-3:50 p.m. Structure-Based Ligand Discovery for GPCRs Ruben Abagyan, Ph.D., Professor, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego The Role of Recent Crystal Structures of Membrane Bound Proteins in Drug Discovery for CNS Targets Sid Topiol, Ph.D., CSO, Computational and Structural Investigations, 3D-2Drug Hitting a Moving Target: Characterizing GPCR Signaling through Long- timescale Molecular Dynamics Simulations Ron Dror, Ph.D., Senior Research Scientist and Special Advisor to the Chairman, D. E. Shaw Research Beyond the Orthosteric Binding Site: A Structure-Based SAR Analysis of the D3R Selective Compounds Lei Shi, Ph.D., Assistant Professor, Department of Physiology and Biophysics, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medical College Moving in New Circles - Exploiting Macrocycles for Drug Discovery Nick Terrett, Ph.D., CSO, Ensemble Therapeutics Corp View full details and register at: http://www.healthtech.com/sbd or call 781-972-5400. Those that register by April 29 will receive the advanced registration discount. - James Prudhomme James Prudhomme Marketing Manager Cambridge Healthtech Institute Tel: 781-972-5486 [email protected] _______________________________________________ BBB mailing list [email protected] http://www.bioinformatics.org/mailman/listinfo/bbb
